ADVFN ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Premium IconPremium Help Menu
S&P 500
6,262.14
0.59%
US Tech 100
22,243.20
0.68%
Dow Jones
44,466.56
0.51%
Brent Oil
69.715
0.09%
Bitcoin
111,701.00
2.54%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. UroGen Pharma Ltd (URGN) Quote

UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

NASDAQ
13.82
0.11
( 0.80% )
Updated: 15:41:18
15 min delayed - Upgrade to Realtime

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Key stats and details

Current Price
13.82
( 0.80% )
Bid
13.82
Ask
13.85
Volume
1,052,896
13.5654 Day's Range 14.31
3.42 52 Week Range 18.15
Market Cap
637.205M
Previous Close
13.71
Open
13.84
Last Trade
21
@
13.8355
Last Trade Time
15:41:18
Financial Volume
$ 14,606,047
VWAP
13.8723
Average Volume (3m)
3,089,132
Shares Outstanding
46,107,451
Dividend Yield
-
PE Ratio
-5.14
Earnings Per Share (EPS)
-2.75
Revenue
90.4M
Net Profit
-126.87M

About UroGen Pharma Ltd

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.urogen.com
Headquarters
Ra'anana, Center, Isr
Founded
-
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was $13.71. Over the last year, UroGen Pharma shares have traded in a share price range of $ 3.42 to $ 18.15.

UroGen Pharma currently has 46,107,451 shares outstanding. The market capitalization of UroGen Pharma is $632.13 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -5.14.

Ask ADVFN Intelligence (AI)

URGN Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
July 03 2025
URGN (0.80%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
June 16 2025
URGN (0.80%)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Edgar (US Regulatory)
June 13 2025
URGN (0.80%)

Form 8-K - Current report
Edgar (US Regulatory)
June 13 2025
URGN (0.80%)

Form 4 - Statement of changes in beneficial ownership of securities
Edgar (US Regulatory)
June 11 2025
URGN (0.80%)

Form 144 - Report of proposed sale of securities
Edgar (US Regulatory)
June 10 2025
URGN (0.80%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.947.2981366459612.8814.3112.73103371413.31356504CS
46.794.10112359557.1215.616.92454605112.53545382CS
123.0828.67783985110.7415.613.4230891329.40983099CS
262.8726.210045662110.9515.613.4216692619.55121801CS
52-2.24-13.947696139516.0618.153.42107742510.42791894CS
1565.2461.07226107238.5824.133.4255210812.12146958CS
260-10.54-43.267651888324.3628.23.4239154312.66841394CS

URGN - Frequently Asked Questions (FAQ)

What is the current UroGen Pharma share price?
The current share price of UroGen Pharma is $ 13.82
How many UroGen Pharma shares are in issue?
UroGen Pharma has 46,107,451 shares in issue
What is the market cap of UroGen Pharma?
The market capitalisation of UroGen Pharma is USD 632.13M
What is the 1 year trading range for UroGen Pharma share price?
UroGen Pharma has traded in the range of $ 3.42 to $ 18.15 during the past year
What is the PE ratio of UroGen Pharma?
The price to earnings ratio of UroGen Pharma is -5.14
What is the cash to sales ratio of UroGen Pharma?
The cash to sales ratio of UroGen Pharma is 7.21
What is the reporting currency for UroGen Pharma?
UroGen Pharma reports financial results in USD
What is the latest annual turnover for UroGen Pharma?
The latest annual turnover of UroGen Pharma is USD 90.4M
What is the latest annual profit for UroGen Pharma?
The latest annual profit of UroGen Pharma is USD -126.87M
What is the registered address of UroGen Pharma?
The registered address for UroGen Pharma is 9 HATAASIYA ST, PO BOX 2397, RA'ANANA, CENTER, 4365007
What is the UroGen Pharma website address?
The website address for UroGen Pharma is www.urogen.com
Which industry sector does UroGen Pharma operate in?
UroGen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WWWW International Inc
$ 39.565
(15,751.36%)
229.15k
SUGPSU Group Holdings Ltd
$ 1.2998
(189.17%)
193.97M
EVOKEvoke Pharma Inc
$ 6.90
(159.40%)
136.19M
BMGLBasel Medical Group Ltd
$ 3.4399
(89.01%)
81.74M
IMGCIMG Inc
$ 0.3487
(52.27%)
13.71M
PHHPark Ha Biological Technology Company Ltd
$ 1.1392
(-61.90%)
16.3M
RXSTRxSight Inc
$ 7.88
(-38.39%)
15.57M
PETWag Group Company
$ 0.183799
(-27.78%)
5.28M
BGLBlue Gold Limited
$ 39.47
(-27.44%)
467.95k
BCTXBriaCell Therapeutics Corporation
$ 2.12
(-27.15%)
6.06M
NCNANuCana PLC
$ 0.0608
(9.35%)
1.73B
GIBOGIBO Holdings Ltd
$ 0.03425
(-17.07%)
237.29M
PLUGPlug Power Inc
$ 1.81
(27.46%)
212.97M
PROKProKidney Corporation
$ 4.4388
(19.00%)
204.88M
SUGPSU Group Holdings Ltd
$ 1.2904
(187.07%)
193.97M

Discussion

View Full Feed
surfer44 surfer44 38 seconds ago
Ramblin Gamblin man (Drive video)

https://youtu.be/1DapCef8oLI
GOLD
pos_stock_hoarder pos_stock_hoarder 52 seconds ago
A new one to me! Always fun when that happens!
livefree_ordie livefree_ordie 56 seconds ago
Final answer, more research needs to done to see if what their findings were are really true or not more needs to be done says the researcher with the smaller amygdala!!!. Definitely sounds like a total confirmation of the data to me????
aBeezlee aBeezlee 1 minute ago
Is 8486106d an alternate account for Robin? Only 6 posts and all on this board. 🤔
VRSSF
NebraskaOTC NebraskaOTC 1 minute ago
Enjoy your water crew SCAM.

Sorry for your loss, Bud! :-D
FUNR
236T568 236T568 1 minute ago
Stephen Miller finally gets his revenge on L.A.

https://www.latimes.com/california/story/2025-07-09/stephen-miller-finally-gets-his-revenge-on-l-a
cryptobro1990 cryptobro1990 1 minute ago
“Junior”? Bro, it’s 2025 — no one says that anymore. You sound like a Blockbuster manager trying to sound edgy on TikTok.

We all know your game. No DD. No breakdowns. No position. Nothing useful, Just noise. It’s lazy, transparent, and weirdly helpful every one of your empty posts pus
CGAC
getmoreshares getmoreshares 1 minute ago
19m ask at 4-- 288m bid at 3
CGAC
StayHumble StayHumble 2 minutes ago
✅💹Filing PROVES MOASS Coming💹$PDIV GOING UP✅🎃
https://miro.medium.com/v2/resize:fit:952/1*IqZuwhoPTUeWbgwX30I0JA.gif

'......wow Xpert Traitors.......wow"


https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
PDIV
Trooperstocks Trooperstocks 2 minutes ago
Bitcoin ripping right now, our investment looks to be a very wise choice. $KULR
KULR
Birdbrain Ideas Birdbrain Ideas 2 minutes ago
Amarin won't agree to sell itself for $35 to $40 a share. That would be silly. The share price over the past year has reflected Wall Street's belief that investing in Amarin was a bet against bankruptcy and not much more. I think a more realistic buyout range would be $5 to $10 pre-split and $100 to
AMRN
StayHumble StayHumble 2 minutes ago
💹GreensNaturalFoods💹doubles $HCWC✅Revenue $75Million+💹💹 @healthiercmc
https://www.healthiercmc.com/news/20221017-greens-natural-foods

https://static1.squarespace.com/static/58a1d7b8893fc0b6d3e47931/t/63599cf2e6708456f8187f4c/1666817273168/
HCWC
Helloman1 Helloman1 2 minutes ago
BTW what the hell is a pufladder ? LMAO. I guess he's puffing on something while sitting on a later.
TWOH
PennyMillions852 PennyMillions852 2 minutes ago
💩💩💩💩💩💩
BIEI
Skankhunt43 Skankhunt43 3 minutes ago
Down here we're alll dennis
DPLS
jhdf51 jhdf51 3 minutes ago
Yep, and combine that with the inevitable rate lowering it will be great!

JHD
COOP
dangriff dangriff 3 minutes ago
You know what I'd love to happen, some big news that causes the stock to finally start its scale up to stop conversations about you timing the market. It's a hope. Not likely to happen I guess, but a hope none the less.
CBRF
vlispxpert vlispxpert 3 minutes ago
I R W D .80's here, nice & sunny day ;)
rheddle rheddle 3 minutes ago
I was pretty close. Would be nice to move up from here into the close after the consolidation.
DTREF
dinogreeves dinogreeves 4 minutes ago
Pretty much that how it goes here, but we know who has been here all this time, but we also have to consider the bag holders that have simply forgotten this.
CDSG
iamadog iamadog 4 minutes ago
Gap filled, to some it's not important. To the market makers it's another tool  to control price . 
VMST
SmoothTrader61 SmoothTrader61 4 minutes ago
Always a large block for sale 
VMST
Barunuuk Barunuuk 4 minutes ago
OMG! You do know that with MHRA approval, DCVAX will become the Standard of Care, and being approved by NHS and the UK that has universal health care, IT MEANS ALL GBM CASES WILL MOST LIKELY GET THIS CARE. Wow. So GBM alone has the potential for >$1B of revenue. You include all other Cancers
NWBO
TaperT2 TaperT2 4 minutes ago
Is ELOn in that BTC Rocket 
BTCUSD
StayHumble StayHumble 5 minutes ago
💹 $100+$DJT MOASS Coming✅Naked Shorts? Depends.🇺🇸✅💹
https://media3.giphy.com/media/v1.Y2lkPTc5MGI3NjExbHU5YTBrempjNHMxajQwemkzMm0zYmVtcG9iamI1dnBsd2xrdnAyOSZlcD12MV9pbnRlcm5hbF9naWZfYnlfaWQmY3Q9Zw/bJ8zSwl4QzBiE/giphy.gif
https://youtu.be/i
DJT

Your Recent History

NASDAQ
URGN
UroGen Pharma
Delayed Upgrade Clock
ADVFN
InvestorsHub
United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN Ltd - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads